VRXA
Veraxa Biotech Holding AG
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 6/18/2026 | View on SEC |
| 20-F | 6/16/2026 | View on SEC |
| SCHEDULE 13D | 6/16/2026 | View on SEC |
| SCHEDULE 13D | 6/16/2026 | View on SEC |
| SCHEDULE 13D | 6/15/2026 | View on SEC |
| SCHEDULE 13D | 6/15/2026 | View on SEC |
| 6-K | 6/11/2026 | View on SEC |
| CERT | 6/10/2026 | View on SEC |
| 8-A12B/A | 6/10/2026 | View on SEC |
| 3 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VRXA |
| Company Name | Veraxa Biotech Holding AG |
| CIK | 2079109 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 41443858450 |